Get all your news in one place.

100’s of premium titles.
One app.

Start reading

Get all your news in one place.

100’s of premium titles. One news app.

Start reading

The Latest Breaking News from diabetes

Claim PIP for diabetes and you could get up to £627 every month from the DWP

More than 33,490 people across the UK living with diabetes are receiving financial support through PIP.

Daily Record

10 amazing health benefits of losing half a stone

Losing as little as seven pounds can do great things for your physical health.

Daily Record

Insulet Q1 Earnings Beats Street View, Says Omnipod 5 Rollout Is 'Progressing Very Well'

Insulet Corporation (NASDAQ:PODD) posted Q1 profits of $27.8 million, or an EPS of $0.40, beating the consensus of $0.23. Q1 sales increased 17.1% Y/Y, or 19.3% in constant currency, to $295.4 million, exceeding the guidance range of 13% to 16% in constant currency and the consensus of $288.18 million. “We are off…

Benzinga

From analysis to the latest developments in health,
read the most diverse news in one place.

Dominic Littlewood's career was nearly cut short at 24 after accident on holiday

Dominic Littlewood's health scares haven't stopped him forging a successful tv career but a holiday accident nearly changed all that

Daily Mirror

Vegan diet can help overweight people shed pounds, study shows

Eating vegan for 12 weeks also led to lower blood sugar levels in overweight people or with type 2 diabetes

The Guardian - UK

Vegan diets help people shed pounds and lower blood sugar levels – study

In comparison with control diets, vegan diets reduced body weight on average by about 4.1kg, the study found.

The Independent UK

Vegan diets ‘help people shed pounds and lower blood sugar levels’

The studies showed that, in comparison with control diets, vegan diets reduced body weight

Bristol Post

Read news from The Economist, FT, and more,
with one subscription

6 Analysts Have This to Say About Tandem Diabetes Care

Within the last quarter, Tandem Diabetes Care (NASDAQ:TNDM) has observed the following analyst ratings:

Benzinga

Tandem Diabetes' Q1 Bottom-Line Slide Deeper Into Red Despite Sales Growth

Tandem Diabetes Care Inc (NASDAQ:TNDM) posted Q1 losses of $(0.23) deeper than $(0.08) posted a year ago and missing the consensus of $(0.07). Sales increased 25% to $175.91 million, beating the consensus of $168.43 million. Worldwide pump shipments increased 11% Y/Y to 28,095. The gross margin remained almost unchanged at 52%. The company…

Benzinga

Recap: Tandem Diabetes Care Q1 Earnings

Tandem Diabetes Care (NASDAQ:TNDM) reported its Q1 earnings results on Wednesday, May 4, 2022 at 04:05 PM. Here's what investors need to know about the announcement.

Benzinga

Ten incredible benefits losing half a stone does for your health

Dieticians have claimed if a person loses just 7lb can do wonders for your physical health immediately and long-term.

Daily Record

Ten remarkable benefits losing half a stone does for your health

Dieticians believe shedding just 7lb can do wonders for your physical health in many ways

Wales Online

Vet saves dog from being put to sleep by owners who could not afford medical care

Now Teddy is in foster care and having two insulin shots every day

Belfast Live

Vertex Pharma's Stem Cell Derived Diabetes Treatment Trial Put On Hold

The FDA has instituted a clinical hold on Vertex Pharmaceuticals Incorporated's (NASDAQ:VRTX) VX-880 Phase 1/2 study due to a determination that there is insufficient information to support dose escalation with the product. VX-880 is an investigational stem cell-derived, fully differentiated pancreatic islet cell replacement therapy for type 1 diabetes (T1D). Three patients have been…

Benzinga

Get all your
news in one place.

100’s of premium titles.
One news app.

Liverpool Echo

81 tributes and funeral notices from across Merseyside this week

The past week's notices from around the region

Salon

Gaetz inaccurate diagnosis of insulin

Health economists and diabetes experts weigh in on Gaetz’s faulty cause-and-effect argument that "doesn't exist"

Manchester Evening News

Mum of Manchester aid worker 'living worst nightmare' after son 'captured by Russian forces in Ukraine'

Paul Urey, who is thought to be from Manchester, has Type 1 Diabetes and requires daily insulin

Benzinga

AstraZeneca Clocks Q1 COVID Vaccine Sales Of $1.2B, Keeps Overall FY22 Outlook

AstraZeneca Plc's (NASDAQ:AZN) total revenue jumped 60% Y/Y at CER to $11.39 billion in Q1 FY22, beating the consensus of $10.99 billion. The growth reflects the contribution of the Alexion medicines and several Vaxzevria contracts that are expected to complete the delivery by half year 2022. Core EPS came in at $1.89,…

Get all your
news in one place.

100’s of premium titles.
One news app.

Benzinga

Lilly's Tirzepatide Shows Up To 22.5% Weight Loss In New Phase 3 Readout

Eli Lilly And Co (NYSE:LLY) reported topline results from SURMOUNT-1 Phase 3 trial evaluating Tirzepatide (5 mg, 10 mg, 15 mg) in obese patients with at least one comorbidity who do not have diabetes. Data exhibited that tirzepatide reduced patients' weights by an average of 16%, 21.4%, and 22.5% at the respective doses,…

Benzinga

Novo Nordisk's Once-Weekly Insulin Icodec Shows Favorable Reduction In HbA1c In Type 2 Diabetes

Novo Nordisk A/S (NYSE:NVO) has announced topline results from Phase 3a ONWARDS 2 trial, 26-week efficacy and safety treat-to-target trial investigating once-weekly insulin icodec vs. insulin degludec. The study included 526 people with type 2 diabetes switching from daily insulin. The trial achieved its primary endpoint of demonstrating non-inferiority in reducing HbA1c at…

Dynamite News

Health: Parental diabetes can affect children's mental growth

Children's cognitive development can be affected regardless of whether their biological parents have type 1 diabetes. Read full story on Dynamite News:

The Hindu

‘Teleophthalmic service can prevent blindness due to diabetes’

Image of retina can be analysed and results given within 30 minutes, says Dr. V. Mohan

Benzinga

Insulet Highlights New Data For Omnipod 5 System For Type 1, Type 2 Diabetes

Insulet Corporation (NASDAQ:PODD) unveiled study results for the new Omnipod 5 automated insulin delivery system in type 1 and type 2 diabetes patients. Paired with DexCom Inc's (NASDAQ:DXCM) G6 continuous glucose monitoring (CGM) system, Omnipod 5 is the first tubeless, wearable, automated insulin delivery system. Related: FDA Approves Insulet's Omnipod Automated Insulin Delivery System Patients…

The Independent UK

Diabetes patients more likely to have feet amputated if they live in poor areas

Belfast Live

Weight loss success for mum with type two diabetes after losing more than eight stone

Elma has successfully reversed her illness through weight loss

1 … 94 95 96 97

People

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

British Heart Foundation

Macmillan Cancer Support

122 stories

VRTX

110 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.